Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+12.3%
5Y CAGR+2.3%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+12.3%/yr
vs +39.0%/yr prior
5Y CAGR
+2.3%/yr
Recent acceleration
Acceleration
-26.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.08B | +21.5% |
| 2024 | $885.05M | +12.2% |
| 2023 | $788.73M | +3.8% |
| 2022 | $760.22M | -13.8% |
| 2021 | $881.76M | -8.2% |
| 2020 | $960.57M | +146.8% |
| 2019 | $389.24M | +91.2% |
| 2018 | $203.53M | +11.8% |
| 2017 | $182.13M | +563.9% |
| 2016 | $27.43M | - |